Omega Diagnostics Group PLC PDMR Dealing (9918L)
April 24 2018 - 11:04AM
UK Regulatory
TIDMODX
RNS Number : 9918L
Omega Diagnostics Group PLC
24 April 2018
Omega Diagnostics Group PLC
("Omega" or the "Company")
PDMR Dealing
Omega (AIM: ODX), the medical diagnostics company focused on
allergy, food intolerance and infectious disease, announces that it
was notified on 24 April 2018 that Edward Valente, Group R&D
Director of the Company has purchased 124,044 ordinary shares of 4
pence each in the capital of the Company ("Ordinary Shares") at a
price of 14.5 pence per Ordinary Share.
Accordingly, the Company makes the following announcement and
notification in accordance with the EU Market Abuse Regulation (No
596/2014):
1) Details of Persons Discharging Managerial
Responsibilities "PDMR" / person closely
associated with them ('PCA')
a) Name Edward Valente
2. Reason for notification
b) Position / Group R&D Director
status
c) Initial notification Initial Notification
/ amendment
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
b) Name Omega Diagnostics Group plc
c) LEI 2138007U9P4BTZTYIR92
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
a) Description Purchase of Ordinary Shares
of the financial GB00B1VCP282
instrument
Identification
code
b) Nature of Purchase of Ordinary Shares
the transaction
c) Price(s) and Volume(s) Price(s) GBP
volume(s) 124,044 0.145
d) Aggregated Aggregate Volume(s) Volume weighted
information average Price)
Aggregated GBP
volume Price 124,044 0.145
e) Date of the 24/04/18
transaction
f) Place of the LSE
transaction
Contacts:
Omega Diagnostics Group Tel: 01259 763 030
PLC
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group
Finance Director
Jag Grewal, Group Sales
and Marketing Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/James Thompson
(Corporate Finance)
Camille Gochez (Corporate
Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKQDKABKDBQB
(END) Dow Jones Newswires
April 24, 2018 12:04 ET (16:04 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024